This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mobile Applications Are Revolutionising Healthcare, Says Frost & Sullivan

Another obstacle comes from physicians who may not encourage or even dissuade patients from the use of mHealth apps. Clinicians fear that as consumers become empowered with information about price, quality, services, and wait times, doctors will lose control over revenues and how medicine is practiced. They are afraid that the traditional role of the doctor as a guide to health treatments will weaken as consumers rely on mobile health apps or access Websites on their smart phones to direct their own healthcare.

While tablets and smart phones combined with mobile apps have the potential to improve patient care, apps should provide some clinical decision-making data to truly add any value to the quality of care. However, without quality clinical research to back them up, they may be a waste of IT resources.

Nevertheless, with telehealth and at-home care for the aging emerging as new care delivery models, rising adoption of mobile devices and advancing mobile technology, the demand for mHealth apps will continue to grow.

"With more personalized, sophisticated, web-based healthcare applications there is a promising market for health apps developers and technology vendors," says Ms Filar. "Further, mobile network operators have started to tap into these opportunities and perceive mHealth as a natural extension of their core activities. Moreover, with the huge influx of medical data from sensors and other devices, there will be an increased need for advanced data analytics tools and companies focused on data management. The business around mHealth should thrive and become mutually beneficial for all involved," she concludes.

If you would like to learn more about mobile apps in healthcare, please send an email to Joanna Lewandowska, Corporate Communications, at Please include your full contact details in the query.

Frost & Sullivan's ICT for Vertical Markets research programme gives business leaders the understanding upon which to base defensive and offensive vertical strategies. Part of the programme – ICT in European Public Sector – provides valuable insight into business needs and technology requirements, and offers a means by which to benchmark your strategies against the wider industry.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs